You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

List of Excipients in API topiramate tablet

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing topiramate tablet

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC	Excipient
DIRECT RX	topiramate tablet	61919-185	CELLULOSE, MICROCRYSTALLINE
DIRECT RX	topiramate tablet	61919-185	COLLOIDAL SILICON DIOXIDE
DIRECT RX	topiramate tablet	61919-185	FERRIC OXIDE YELLOW
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for topiramate tablet

Excipient focus: CELLULOSE, MICROCRYSTALLINE

topiramate tablet drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: COLLOIDAL SILICON DIOXIDE

topiramate tablet drug variants containing COLLOIDAL SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing COLLOIDAL SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

topiramate tablet drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSES

topiramate tablet drug variants containing HYPROMELLOSES

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing HYPROMELLOSES

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

topiramate tablet drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

topiramate tablet drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 400

topiramate tablet drug variants containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

topiramate tablet drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: STARCH, PREGELATINIZED CORN

topiramate tablet drug variants containing STARCH, PREGELATINIZED CORN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing STARCH, PREGELATINIZED CORN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

topiramate tablet drug variants containing TALC

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing TALC

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

topiramate tablet drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
DIRECT RX	topiramate tablet	61919-185
>Company	>Ingredient	>NDC

topiramate tablet drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.